Chemoinformaics analysis of 3,6,6,9-Bisepoxy-farnesa-1,7(14),10-triene
| Molecular Weight | 234.339 | nRot | 2 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 13 |
| Exact Molecular Weight | 234.162 | nRing | 2 |
| Solubility: LogS | -3.357 | nHRing | 2 |
| Solubility: LogP | 3.54 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 41.3234 |
| nHD | 0 | BPOL | 25.5426 |
| QED | 0.677 |
| Synth | 5.352 |
| Natural Product Likeliness | 2.846 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.086 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.479 |
| MDCK | 0.0000238 |
| BBB | 0.464 |
| PPB | 0.8473 |
| VDSS | 1.682 |
| FU | 0.121609 |
| CYP1A2-inh | 0.057 |
| CYP1A2-sub | 0.942 |
| CYP2c19-inh | 0.199 |
| CYP2c19-sub | 0.929 |
| CYP2c9-inh | 0.054 |
| CYP2c9-sub | 0.068 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.26 |
| CYP3a4-inh | 0.535 |
| CYP3a4-sub | 0.886 |
| CL | 14.952 |
| T12 | 0.174 |
| hERG | 0.008 |
| Ames | 0.921 |
| ROA | 0.035 |
| SkinSen | 0.303 |
| Carcinogencity | 0.917 |
| EI | 0.537 |
| Respiratory | 0.338 |
| NR-Aromatase | 0.109 |
| Antiviral | Yes |
| Prediction | 0.918452 |